Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Variation in Chronic Automated Red Cell Exchange Practices for Sickle Cell Disease: Insights Into Isovolemic Hemodilution Use.

Journal of clinical apheresis·2026
Same author

An Annual Review of Important Apheresis Articles in 2025 From the American Society for Apheresis Attending Physician Subcommittee.

Journal of clinical apheresis·2026
Same author

Red cell antibody and antigen patterns in patients with sickle cell disease: A multi-center analysis.

Transfusion·2026
Same author

Clinical significance of anti-M in pregnancy and self-reported ancestry: The BEST collaborative study.

Transfusion·2026
Same author

A Primer on Gene Editing: What Does It Mean for Pathologists?

Archives of pathology & laboratory medicine·2025
Same author

An Annual Review of Important Apheresis Articles in 2024 From the American Society for Apheresis Attending Physician Subcommittee.

Journal of clinical apheresis·2025
Same journal

Sentiment Analysis of Acceptance TVET Online Courses on the Skill Academy App from Google Play: Leveraging Text Mining with Comparison Machine Learning Model.

F1000Research·2026
Same journal

Emotional intelligence: An important skill to learn now more than ever.

F1000Research·2026
Same journal

East Mediterranean Lineage of <i>Brucella melitensis</i> in Human Isolates and Milk Samples in Oman Using MLVA-14.

F1000Research·2026
Same journal

Application of K-Means Clustering for Job Applicant Analysis in Construction Firms Using R.

F1000Research·2026
Same journal

The influence of self-esteem and emotional intelligence on addiction to social networks in Peruvian university students.

F1000Research·2026
Same journal

A Bibliometric Analysis of Music's Role in Promoting Well-Being in Health Science Research.

F1000Research·2026
See all related articles

Related Experiment Video

Updated: Dec 25, 2025

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

1.1K

Platelets treated with pathogen reduction technology: current status and future direction.

Wen Lu1, Mark Fung2

  • 1Section of Transfusion Medicine, Robert Tomsich Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.

F1000Research
|February 13, 2020
PubMed
Summary
This summary is machine-generated.

Pathogen-reduced platelets (PRPs) offer enhanced safety by reducing bacterial contamination and infectious agent risks. Ongoing research evaluates their transfusion outcomes, pediatric use, and alloimmunization potential, guiding future implementation.

Keywords:
HLA alloimmunizationPRT-treated plateletspathogen reduction technologypathogen-reduced plateletsseptic transfusion reactionstransfusion-transmitted infections

More Related Videos

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
10:32

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination

Published on: August 24, 2015

14.0K
Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
12:40

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Published on: December 7, 2012

29.4K

Related Experiment Videos

Last Updated: Dec 25, 2025

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

1.1K
Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
10:32

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination

Published on: August 24, 2015

14.0K
Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
12:40

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Published on: December 7, 2012

29.4K

Area of Science:

  • Transfusion Medicine
  • Infectious Disease Prevention
  • Biotechnology

Background:

  • Pathogen reduction technology (PRT) for platelets is increasingly adopted in the US.
  • PRT-treated platelets (PRPs) aim to mitigate sepsis risk from bacterial contamination.
  • PRPs offer potential protection against known, new, and emerging infectious agents.

Purpose of the Study:

  • Review available PRP products and their benefits.
  • Examine unresolved questions and pivotal research on PRP transfusion outcomes.
  • Discuss PRP use in pediatric patients and association with HLA alloimmunization.

Main Methods:

  • Literature review of PRP products and clinical studies.
  • Comparison of transfusion outcomes between PRPs and conventional platelets (CPs).
  • Analysis of studies on pediatric PRP use and HLA alloimmunization.

Main Results:

  • PRPs demonstrate potential to reduce transfusion-related infectious risks.
  • Comparative studies largely focus on adult transfusion outcomes.
  • Emerging data address pediatric applications and alloimmunization concerns.

Conclusions:

  • Continued evaluation of PRP risks, benefits, and newer technologies is critical.
  • Reassessment of financial implications is necessary for informed PRP implementation.
  • Evidence-based decision-making is key for transfusing pathogen-reduced platelets.